AstraZeneca asks Fda ok on therapy to prevent Covid – Healthcare

AstraZeneca asks Fda ok on therapy to prevent Covid – Healthcare
AstraZeneca asks Fda ok on therapy to prevent Covid – Healthcare

The pharmaceutical company AstraZeneca has asked the US Food and Drug Administration to approve with emergency authorization what could prove to be the first antibody-based treatment to prevent symptomatic Covid in immuno-compromised people, or who cannot get the vaccine for reasons of health.

The therapy – in acronym AZD7442 – would be precisely the first long-acting antibody combination, aimed at specific population groups, offering an alternative to immunization for those who do not respond adequately to vaccines.

REPRODUCTION RESERVED © Copyright ANSA

Source

AstraZeneca asks Fda therapy prevent Covid Healthcare

PREV Tiredness, back pain and headache are some of the symptoms caused by this condition
NEXT Those who take these medications for pressure and others should pay attention to this autumn fruit